Company Data

Calliditas Therapeutics AB

Ticker
CALT
Current Price
$40.0001
Market Cap
$1.1B
Price Target
Refer to Report
Volume
710
52wk Range
$16 - $43
Advanced Market Data

Overview

Calliditas Therapeutics AB is a biopharmaceutical company in Sweden. The company is engaged in the provision of pharmaceutical products for patients with niche indications. It is focused on the development and commercialization of the product candidate Nefecon intended for the treatment of patients with the inflammatory renal disease IgA nephropathy, a disease that causes chronic inflammation of the kidneys.

Inbox Intel from Channelchek.

Informed investors make more money. And itā€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy